Clinical Trial Update: Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports Phase 1 and Phase 2 results for ARO-HSD in healthy volunteers and patients with non-alcoholic steatohepatitis (NASH) or suspected …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• ARO-HSD

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Non-alcoholic Steatohepatitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-10-03